Unpacking Endometrial Cancer with Professor Linda Mileshkin

Pinterest LinkedIn Tumblr +

Endometrial cancer is the most common gynaecological cancer in Australia and advanced disease and early on set disease are increasing.

In today’s episode, our Host Rachael Babin is joined by Professor Linda Mileshkin Director of Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne, Australia.

They discuss new treatment options, clinical trials and collaborative research efforts such as the EDEN initiative.

They also discuss stigma, shame and society’s silence around gynaecological cancers.


Resources & Links:

Visit the ANZGOG website here.

The silence around vulval cancer means people are missing the signs that they have it‘. Sophie Rees, University of Bristol, October 3, 2023. Read here.

Counterpart Organisation

Cancer Council Australia

Guests + Host:

Professor Linda Mileshkin

Linda Mileshkin

Professor Mileshkin is a medical oncologist and a clinical researcher with a particular interest in the treatment of gynaecological cancers as well as Cancer of Unknown Primary (CUP). She is the Director of Medical Oncology at the Peter MacCallum cancer Centre in Melbourne, Australia. She consults both at Peter Mac Melbourne and at the Mercy Hospital for Women in Heidelberg.

Professor Mileshkin is also the Clinical Trials Lead for Gynae-Oncology in the Parkville Cancer Clinical Trials Unit, and the Chair of the Gynaecological Oncology Group for the Clinical Oncology Group of Australia. She is also very involved in the Australia New Zealand Gynaecological Oncology Group (ANZGOG) as the chair of the Endometrial Cancer Research Initiative (EDEN) and a member of multiple sub-committees including the Research Advisory Committee.

Professor Mileshkin also runs Australia’s only specialist clinic dedicated to the care of people affected by Cancer of Unknown Primary (CUP). She is the tumour stream lead for CUP at Peter Mac and has been the clinical lead for the Solving Unknown Primary CancER (SUPER) national cohort study and team of CUP researchers in Australia. This group have been successful in obtaining significant grant finding and have been running multiple clinical and translational projects in CUP.

Rachael Babin

Rachael Babin

Rachael Babin is Host of The Oncology Podcast, Editor-in-Chief of The Oncology Newsletter,  and Publisher of Oncology News Australia and The Oncology Network.

With a background in oncology communications and academic publishing, Rachael is happiest sitting behind the mic chatting to interesting people about the impact their work makes in oncology.

Connect with us on X here: @OncologyNewsAus

Share.

About Author

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.